ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES

Authors

Pranki Shukla

Keywords

Metformin, therapeutical action, antihyperglycemic, Drugs

Abstract

The main objective of this study was to explain the metformin as a marvelous drug beyond diabetes. In earlier days, metformin was used to cure diabetes but in recent days metformin shows different pharmacological actions (as an anticancer, as an antiviral, as an antimalarial, in polycystic ovarian syndrome, in non alcoholic fatty liver disease, as an antiaging, as an anti-inflammatory, in auto immunity, in renal replacement therapy, in hypothyroidism etc.) in living cells. Due to these different many effects of metformin, this biguanide is known as “Sanjivani for human health”.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJRTI — journal style
"METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.6, Issue 9, page no.18 - 20, September-2021, Available :https://ijrti.org/papers/IJRTI2109005.pdf
APA — 7th edition
Shukla, P. (2021). METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. International Journal for Research Trends and Innovation, 6(9), 18 - 20. https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
MLA — 9th edition
Shukla, Pranki. "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES." International Journal for Research Trends and Innovation, vol. 6, no. 9, 2021, pp. 18 - 20, https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005.
Chicago — 17th, bibliography
Shukla, Pranki. "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES." International Journal for Research Trends and Innovation 6, no. 9 (2021): 18 - 20. https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005.
Harvard — author–date
Shukla, P. (2021) 'METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES', International Journal for Research Trends and Innovation, 6(9), pp. 18 - 20. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
IEEE — numbered reference
P. Shukla, "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES," IJRTI, vol. 6, no. 9, pp. 18 - 20, Sep. 2021.
Vancouver — biomedical
Shukla P. METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. IJRTI. 2021 Sep;6(9):18 - 20.
AMA — 11th edition
Shukla P. METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. IJRTI. 2021;6(9):18 - 20. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2109005, author = {Pranki Shukla}, title = {METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES}, journal = {International Journal for Research Trends and Innovation}, volume = {6}, number = {9}, pages = {18 - 20}, year = {2021}, month = {September}, issn = {2456-3315}, url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005} }
RIS — EndNote, RefWorks
TY - JOUR AU - Shukla, Pranki TI - METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES T2 - International Journal for Research Trends and Innovation JA - IJRTI VL - 6 IS - 9 PY - 2021 SN - 2456-3315 UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005 SP - 18 EP - 20 ER -

Issue

Volume 6 Issue 9, September-2021
Pages : 18 - 20

Other Publication Details

Paper Reg. ID IJRTI_181597
Published Paper ID IJRTI2109005
Downloads 205,593
Research Area Pharmacy
Country Lucknow,, Uttar Pradesh, India
Published September 2021

About Publisher

International Journal for Research Trends and Innovation Published by IJRTI (JW Publication)
2456-3315 ISSN
10.57 Impact Factor
2016 ESTD Year
Open Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.

Licence

© 2021 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹599
Publish in a UGC CARE Approved Journal | Low Cost ₹599 Indian Author | 🌐 $45 USD International
CrossRef/DataCite DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →